Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cognito Therapeutics
MedTech
Cognito opens biomarker study of neuromod device in Alzheimer’s
As it races toward FDA review of its light- and sound-based neuromodulation device, Cognito Therapeutics is taking an even closer look at the tech.
Andrea Park
Jan 23, 2024 10:45am
Cognito study shows white matter growth after neuromod treatment
Dec 12, 2023 10:44am
Longtime BioMarin CEO hands off baton—Chutes & Ladders
Nov 3, 2023 9:30am
Cognito taps former BrainStorm president as medical chief
Apr 17, 2023 11:15am
Cognito collects $73M for light-and-sound Alzheimer's therapy
Mar 22, 2023 8:00am
Cognito’s headset slows brain atrophy in Alzheimer's study
Aug 1, 2022 11:19am